The Vanguard Group, Inc. (IRSH)Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc 26-Dec-2025 / 15:08 GMT/BSTAp27   FORM 8.3   IRISH TAKEOVER PANEL   OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE   1. KEY INFORMATION             Full name of discloser The Vanguard Group, Inc.           Owner or controller of interests and short positions discl ...